Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results
Christine D. Palmer, Amy Rappaport, Matthew J. Davis, Meghan G. Hart, Ciaran D. Scallan, Sue‐Jean Hong, Leonid Gitlin, Lauren D. Kraemer, Sonia Kounlavouth, Aaron Yang, Lindsey Smith, Desiree Schenk, Mojca Škoberne, Kiara Taquechel, Martina Marrali, Jason R. Jaroslavsky, Charmaine N. Nganje, Elizabeth Maloney, Rita Zhou, Daniel Navarro-Gomez, Adrienne C. Greene, Gijsbert Marnix Grotenbreg, Renee L. Greer, Wade S. Blair, Minh Duc Cao, and 19 more
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1038/s41591-022-01937-6
- Published
- Aug 1, 2022
- Venue
- Nature Medicine
- DOI
- 10.1038/s41591-022-01937-6
- PubMed
- 35970920
- Categories
- Immunotherapy and Immune Responses
- Provenance
- openalex